Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-09 Sale |
2025-04-11 7:37 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) |
View |
2025-02-14 Purchase |
2025-02-19 5:56 pm |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) |
View |
2024-09-16 Purchase |
2024-09-17 8:05 pm |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
750,000 | $16 | $12,000,000 | 653,787 (Indirect) |
View |
2024-08-13 Sale |
2024-08-15 5:06 pm |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) |
View |
2024-07-15 Sale |
2024-07-17 8:53 pm |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
56,164 | $10 | $561,640 | 755,635 (Indirect) |
View |
2024-05-15 Sale |
2024-05-20 4:39 pm |
BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner |
24,344 | $0.3812 | $9,280 | 13,773,653 (Indirect) |
View |
2024-04-03 Sale |
2024-04-05 4:39 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
8,009,729 | $0 | $0 | 0 (Indirect Direct) |
View |
2024-01-30 Purchase |
2024-01-31 4:11 pm |
ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner |
444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) |
View |
2024-01-25 Purchase |
2024-01-26 7:13 pm |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
3,125,000 | $2.4 | $7,500,000 | 2,930,527 (Indirect) |
View |
2023-07-17 Purchase |
2023-07-19 4:17 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) |
View |
2023-06-27 Purchase |
2023-06-29 4:51 pm |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
875,000 | $2.09 | $1,828,750 | 962,339 (Indirect) |
View |
2023-05-04 Purchase |
2023-05-08 5:11 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) |
View |
2023-04-28 Purchase |
2023-05-02 9:38 pm |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) |
View |
2023-02-27 Purchase |
2023-03-17 4:29 pm |
BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner |
348,000 | $0.245 | $85,260 | 4,951,448 (Indirect) |
View |
2022-12-23 Purchase |
2022-12-28 5:46 pm |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
137,931 | $7.25 | $1,000,000 | 7,619,135 (Indirect) |
View |
2022-11-08 Purchase |
2022-11-10 4:38 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) |
View |
2022-11-07 Purchase |
2022-11-09 4:29 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) |
View |
2022-08-16 Purchase |
2022-08-18 4:50 pm |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
3,690,000 | $2.42 | $8,929,800 | 1,072,400 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-11 Option Award |
2025-02-13 5:08 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
2024-11-01 Conversion |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
539,062 | $3.2 | 2,677,256 (Indirect) |
View | |
2024-11-01 Option Award |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
1,443,750 | $4 | 2,677,256 (Indirect) |
View | |
2024-11-01 Conversion |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
1,233,506 | $0 | 2,677,256 (Indirect) |
View | |
2024-11-01 Conversion |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
694,444 | $3.6 | 2,677,256 (Indirect) |
View | |
2024-09-16 Conversion |
2024-09-17 8:05 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
39,876,501 | $0 | 653,787 (Indirect) |
View |
2024-09-12 Option Award |
2024-09-13 5:19 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
15,963 | $0 | 15,963 (Direct) |
View |
Ownership |
2024-09-12 7:15 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | GORDON CARL L Director 10% Owner |
0 | $0 | 3,062,215 (Indirect) |
View |
2024-08-21 Option Award |
2024-08-23 4:08 pm |
N/A 2030-09-16 |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
93,400 | $0 | 93,400 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:36 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
4,676 | $0 | 4,676 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:04 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
32,000 | $0 | 32,000 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:08 pm |
N/A 2034-06-04 |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
32,300 | $0 | 11,485,340 (Direct) |
View |
2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
10,000 | $0 | 10,000 (Direct) |
View |
2024-05-15 Exercise |
2024-05-20 4:39 pm |
N/A N/A |
BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner |
9,280,408 | $0.244 | 13,773,653 (Indirect) |
View |
2024-05-15 Exercise |
2024-05-20 4:39 pm |
2023-05-04 2033-05-04 |
BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner |
9,280,408 | $0 | 13,773,653 (Indirect) |
View |
2024-02-14 Equity Swap |
2024-02-14 4:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
17,713,600 | $0 | 0 (Indirect) |
View |
2024-02-09 Option Award |
2024-02-14 12:02 pm |
N/A 2034-02-08 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
2024-01-30 Conversion |
2024-01-31 4:11 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner |
2,582,884 | $0 | 1,513,664 (Indirect) |
View |
Ownership |
2024-01-25 8:36 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner |
0 | $0 | 2,582,884 (Indirect) |
View |
2023-08-14 Option Award |
2023-08-16 6:08 pm |
N/A 2030-09-16 |
Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner |
93,400 | $0 | 93,400 (Direct) |
View |
2023-06-12 Option Award |
2023-06-14 7:01 pm |
N/A 2033-06-11 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
32,000 | $0 | 32,000 (Direct) |
View |
2023-06-12 Option Award |
2023-06-13 6:29 pm |
N/A 2033-06-12 |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-13 Option Award |
2023-06-13 5:29 pm |
N/A 2033-06-12 |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
22,750 | $0 | 22,750 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 4:48 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
10,000 | $0 | 10,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-02 5:47 pm |
N/A 2033-05-31 |
Adicet Bio Inc. | ACET | GORDON CARL L Director |
32,300 | $0 | 32,300 (Direct) |
View |
2023-02-17 Option Award |
2023-02-22 4:30 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner |
550,000 | $0 | 4,593,629 (Indirect) |
View |
2023-02-08 Option Award |
2023-02-09 4:28 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
60,000 | $0 | 60,000 (Direct) |
View |